SAI MedPartners and IDEA Pharma launch first ever China Pharmaceutical Innovation and Invention Index
– First ever launch of China Index recognizes the increased strength of innovation in Chinese Pharma and Biotech and its […]
News
SAI MedPartners Enhances Its Competitive Intelligence Capabilities Through the Acquisition of The Dunn Group
SAI MedPartners Enhances Its Competitive Intelligence Capabilities Through the Acquisition of The Dunn Group December 3, 2025 Reading, PA SAI
2025 Collaborating for Novel Solutions (CNS) Summit: Annual Pharma Digital Innovation Index, cements leaders in the Biopharmaceutical innovation of digital solutions.
Tuesday, November 4th, 2025, Boston, MA – Today, the annual Pharmaceutical Digital Innovation Index, a partnership between IDEA Pharma, a
Introducing the China PIII: A New Benchmark for Pharmaceutical Innovation in China
Shanghai, China – June 10, 2025 – As China advances its national strategy to foster pharmaceutical innovation and drive high-quality
SAI MedPartners Expands Strategic Service Offering Through Acquisition of IDEA Pharma
READING, Pa.–(BUSINESS WIRE)–SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device
SAI MedPartners Acquires PharmaForce
READING, Pa.–(BUSINESS WIRE)–SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device
SAI MedPartners Expands Its Strategic Insights Capabilities Through Acquisition of Fulcrum Research Group
READING, Pa.–(BUSINESS WIRE)–SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device
Northlane Capital Partners Invests in SAI MedPartners
BETHESDA, Md.–(BUSINESS WIRE)–Northlane Capital Partners (“NCP”) announced today that it has made an investment in SAI MedPartners (“SAI”), a leading